Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Callitas Health Inc (OTC: MPHMF).

Full DD Report for MPHMF

You must become a subscriber to view this report.


Recent News from (OTC: MPHMF)

Callitas Health Interim President & CEO Will Present at the 2018 Proactive's CEO Investors Forum
CINCINNATI, OH & NEW YORK, NY, May 09, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, will sen...
Source: GlobeNewswire
Date: May, 09 2018 08:30
Callitas Health, Inc. Releases Annual Update Letter to Shareholders
CINCINNATI, OH, April 19, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc.  (CSE: LILY, OTCBB: MPHMF, FWB: T3F2) today announced that Interim President and Chief Executive Officer, James Thompson, has issued the following letter to shareholders. Dear Shareholders, We would like to t...
Source: GlobeNewswire
Date: April, 19 2018 09:46
Callitas Health, Inc. Signs Multiple Letters of Intent for Distribution of CannaMint Strips in California
CINCINNATI, OH & LOS ANGELES, CA , April 16, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, focused o...
Source: GlobeNewswire
Date: April, 16 2018 08:00
Callitas Health Announces Response from US FDA on Orphan Drug Designation and Rare Pediatric Disease Designation Requests
CINCINNATI, OH, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative pharmaceutical and OTC technologies for weight management, female sexual hea...
Source: GlobeNewswire
Date: March, 15 2018 08:30
UPDATE: Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
CINCINNATI and NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative pharmaceutical and OTC technologies for weight management, female s...
Source: GlobeNewswire
Date: March, 15 2018 06:00
Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
CINCINNATI and NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative pharmaceutical and OTC technologies for weight management, female s...
Source: GlobeNewswire
Date: March, 13 2018 12:10
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc.  (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, t...
Source: GlobeNewswire
Date: March, 08 2018 18:17
Callitas Health Inc., Announces New Partnership with NFI Consumer Healthcare's e.p.t. Pregnancy Test Line
CINCINNATI, OH, March 05, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, annou...
Source: GlobeNewswire
Date: March, 05 2018 11:27
CALLITAS HEALTH ACCELERATES COMMERCIAL LICENCING AND ENGAGES FEYEUR & TROGUE, A SPECIALTY HEALTHCARE CONSULTING FIRM
CALLITAS HEALTH ACCELERATES COMMERCIAL LICENCING AND ENGAGES FEYEUR & TROGUE, A SPECIALTY HEALTHCARE CONSULTING FIRM
Source: OTC Markets
Date: January, 22 2018 00:00
Callitas Health Engages Dr. Laura Berman, World-renowned Sex Educator, Researcher & Therapist As Chief Health Advisor
CINCINNATI , Jan. 8, 2018 /PRNewswire/ --  Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or "Callitas") a clinical-stage company developing innovative technologies for weight management and female health and wellness, today announced that Dr. Laura Berm...
Source: PR Newswire
Date: January, 08 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-150.12650.12650.12650.126510,000
2018-08-140.12680.12680.12680.12682,000
2018-08-13N/A0.1235N/AN/A0
2018-08-10N/A0.1235N/AN/A0
2018-08-090.1470.12350.1470.12356,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-082,0003,00066.6667Short
2018-07-30800800100.0000Short
2018-07-095,0005,000100.0000Short
2018-07-065005,00010.0000Cover
2018-07-055,8005,800100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MPHMF.


About Callitas Health Inc (OTC: MPHMF)

Logo for Callitas Health Inc  (OTC: MPHMF)

As a company, our number one goal is helping people by bringing products to market that improve quality of life. All our drug treatments and biomedical technologies fit our mission to deliver breakthrough products and services that reduce invasiveness and enhance daily living. We strive to improve the lives of people facing obesity, infertility and intimacy issues. Our products include ground breaking drug treatments and biomedical technologies, including ToConceive, C and Extrinsa.

 

 

 

Current Management

  • James Thompson / CEO
  • Joshua Maurice / Director, Sales amp Mkt.
  • Richard Skeith / D. Richard Skeith received his BA Hons in Economics in and his law degree in , both from the University of Alberta. He has practiced law in Calgary since then. He is currently a partner with a large international law firm, with a practice focused on public company matters. He is currently or has been an officer or director of various public companies in the mining, oil and gas, pharmaceutical and real estate fields.

Current Share Structure

  • Market Cap: $8,395,326 - 03/09/2018
  • Authorized: 32,166,000 - 12/04/2017
  • Issue and Outstanding: 32,166,000 - 12/04/2017

 


Recent Filings from (OTC: MPHMF)

Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: January, 17 2018
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: November, 30 2017
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: October, 21 2017
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: October, 18 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: August, 22 2017
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: July, 17 2017
Annual Report - Certificate of Filings 2017 - CFO
Filing Type: Annual Report - Certificate of Filings 2017 - CFOFiling Source: OTC Markets
Filing Date: May, 24 2017
Annual Report - Certificate of Filings 2017 - CEO
Filing Type: Annual Report - Certificate of Filings 2017 - CEOFiling Source: OTC Markets
Filing Date: May, 24 2017
Quarterly Report - Financial Report March 2017
Filing Type: Quarterly Report - Financial Report March 2017Filing Source: OTC Markets
Filing Date: May, 24 2017
Management Discussion and Analysis - M D & A March 2017
Filing Type: Management Discussion and Analysis - M D & A March 2017Filing Source: OTC Markets
Filing Date: May, 24 2017

 

 


Daily Technical Chart for (OTC: MPHMF)

Daily Technical Chart for (OTC: MPHMF)


Stay tuned for daily updates and more on (OTC: MPHMF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MPHMF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MPHMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MPHMF and does not buy, sell, or trade any shares of MPHMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/